Assembly Biosciences Stock Market Value
| ASMB Stock | USD 28.01 0.39 1.41% |
| Symbol | Assembly |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.60) | Revenue Per Share | Quarterly Revenue Growth 0.576 | Return On Assets | Return On Equity |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Assembly Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Assembly Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Assembly Biosciences.
| 10/27/2025 |
| 01/25/2026 |
If you would invest 0.00 in Assembly Biosciences on October 27, 2025 and sell it all today you would earn a total of 0.00 from holding Assembly Biosciences or generate 0.0% return on investment in Assembly Biosciences over 90 days. Assembly Biosciences is related to or competes with Zura Bio, Foghorn Therapeutics, Immuneering Corp, Sagimet Biosciences, Enanta Pharmaceuticals, Aardvark Therapeutics, and Nautilus Biotechnology. Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for th... More
Assembly Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Assembly Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Assembly Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 18.53 | |||
| Value At Risk | (7.73) | |||
| Potential Upside | 5.88 |
Assembly Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Assembly Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Assembly Biosciences' standard deviation. In reality, there are many statistical measures that can use Assembly Biosciences historical prices to predict the future Assembly Biosciences' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.06) |
Assembly Biosciences January 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 2.82 | |||
| Coefficient Of Variation | (5,406) | |||
| Standard Deviation | 3.82 | |||
| Variance | 14.58 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 18.53 | |||
| Value At Risk | (7.73) | |||
| Potential Upside | 5.88 | |||
| Skewness | (0.35) | |||
| Kurtosis | 0.82 |
Assembly Biosciences Backtested Returns
Assembly Biosciences secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. Assembly Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Assembly Biosciences' Risk Adjusted Performance of (0.01), standard deviation of 3.82, and Mean Deviation of 2.82 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.26, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Assembly Biosciences will likely underperform. At this point, Assembly Biosciences has a negative expected return of -0.0315%. Please make sure to confirm Assembly Biosciences' kurtosis, and the relationship between the value at risk and rate of daily change , to decide if Assembly Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.49 |
Modest reverse predictability
Assembly Biosciences has modest reverse predictability. Overlapping area represents the amount of predictability between Assembly Biosciences time series from 27th of October 2025 to 11th of December 2025 and 11th of December 2025 to 25th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Assembly Biosciences price movement. The serial correlation of -0.49 indicates that about 49.0% of current Assembly Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.49 | |
| Spearman Rank Test | -0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 7.02 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:Check out Assembly Biosciences Correlation, Assembly Biosciences Volatility and Assembly Biosciences Alpha and Beta module to complement your research on Assembly Biosciences. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Assembly Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.